Global Fluid Biopsy Market Overview:
Global Fluid Biopsy Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Fluid Biopsy Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Fluid Biopsy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Fluid Biopsy Market:
The Fluid Biopsy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Fluid Biopsy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Fluid Biopsy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Fluid Biopsy market has been segmented into:
Lung Cancer
Breast Cancer
Colorectal Cancer
and Other Indications
By Application, Fluid Biopsy market has been segmented into:
Circulating Tumor Cells
Circulating Tumor DNA
and Cell-free DNA
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Fluid Biopsy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Fluid Biopsy market.
Top Key Players Covered in Fluid Biopsy market are:
Bio-Rad Laboratories
Guardant Health
Horizon Discovery
Qiagen NV
LungLife AI Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Fluid Biopsy Market Type
4.1 Fluid Biopsy Market Snapshot and Growth Engine
4.2 Fluid Biopsy Market Overview
4.3 Lung Cancer
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Lung Cancer: Geographic Segmentation Analysis
4.4 Breast Cancer
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Breast Cancer: Geographic Segmentation Analysis
4.5 Colorectal Cancer
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Colorectal Cancer: Geographic Segmentation Analysis
4.6 and Other Indications
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 and Other Indications: Geographic Segmentation Analysis
Chapter 5: Fluid Biopsy Market Application
5.1 Fluid Biopsy Market Snapshot and Growth Engine
5.2 Fluid Biopsy Market Overview
5.3 Circulating Tumor Cells
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Circulating Tumor Cells: Geographic Segmentation Analysis
5.4 Circulating Tumor DNA
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Circulating Tumor DNA: Geographic Segmentation Analysis
5.5 and Cell-free DNA
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 and Cell-free DNA: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Fluid Biopsy Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BIO-RAD LABORATORIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 GUARDANT HEALTH
6.4 HORIZON DISCOVERY
6.5 QIAGEN NV
6.6 LUNGLIFE AI INC.
Chapter 7: Global Fluid Biopsy Market By Region
7.1 Overview
7.2. North America Fluid Biopsy Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Lung Cancer
7.2.2.2 Breast Cancer
7.2.2.3 Colorectal Cancer
7.2.2.4 and Other Indications
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Circulating Tumor Cells
7.2.3.2 Circulating Tumor DNA
7.2.3.3 and Cell-free DNA
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Fluid Biopsy Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Lung Cancer
7.3.2.2 Breast Cancer
7.3.2.3 Colorectal Cancer
7.3.2.4 and Other Indications
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Circulating Tumor Cells
7.3.3.2 Circulating Tumor DNA
7.3.3.3 and Cell-free DNA
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Fluid Biopsy Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Lung Cancer
7.4.2.2 Breast Cancer
7.4.2.3 Colorectal Cancer
7.4.2.4 and Other Indications
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Circulating Tumor Cells
7.4.3.2 Circulating Tumor DNA
7.4.3.3 and Cell-free DNA
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Fluid Biopsy Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Lung Cancer
7.5.2.2 Breast Cancer
7.5.2.3 Colorectal Cancer
7.5.2.4 and Other Indications
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Circulating Tumor Cells
7.5.3.2 Circulating Tumor DNA
7.5.3.3 and Cell-free DNA
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Fluid Biopsy Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Lung Cancer
7.6.2.2 Breast Cancer
7.6.2.3 Colorectal Cancer
7.6.2.4 and Other Indications
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Circulating Tumor Cells
7.6.3.2 Circulating Tumor DNA
7.6.3.3 and Cell-free DNA
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Fluid Biopsy Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Lung Cancer
7.7.2.2 Breast Cancer
7.7.2.3 Colorectal Cancer
7.7.2.4 and Other Indications
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Circulating Tumor Cells
7.7.3.2 Circulating Tumor DNA
7.7.3.3 and Cell-free DNA
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Fluid Biopsy Scope:
|
Report Data
|
Fluid Biopsy Market
|
|
Fluid Biopsy Market Size in 2025
|
USD XX million
|
|
Fluid Biopsy CAGR 2025 - 2032
|
XX%
|
|
Fluid Biopsy Base Year
|
2024
|
|
Fluid Biopsy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Bio-Rad Laboratories, Guardant Health, Horizon Discovery, Qiagen NV, LungLife AI Inc..
|
|
Key Segments
|
By Type
Lung Cancer
Breast Cancer
Colorectal Cancer
and Other Indications
By Applications
Circulating Tumor Cells
Circulating Tumor DNA
and Cell-free DNA
|
